Sheryl Roberts, PhD

To define and exploit cancer vulnerabilities, we are building a research program focused on radioligand strategies. Radioligands are specialized drugs that use radioactive isotope to diagnose or treat medical conditions, most commonly cancer. These drugs differ from other diagnostic method or available treatments because they can localized to the target and destroy cancer cells, with the goal of minimizing damage to healthy tissues.